Live Attenuated Human Hookworm Vaccine Shows Promise
Researchers conducted a study to assess the effects of a novel, live attenuated human hookworm vaccine.
Treatments
World Health Organization Releases Updated Guidelines on Treatment Strategies for COVID-19
In this fifth update to the living guidelines on drugs for the treatment of COVID-19, the World Health Organization analyzed results of clinical trials that assessed the effects of casirivimab-imdevimab and corticosteroids in patients with severe and non-severe disease.
Tegaserod Safe, Effective for IBS-C in Women Aged Less Than 65 Years Without Cardiovascular Ischemic Events
Investigators assessed the safety and efficacy of tegaserod in women with IBS-C aged less than 65 years without a history of cardiovascular ischemic events.
Outcomes of Treatment With Convalescent Plasma vs Standard Care in Patients With COVID-19
Investigators conducted a study that compared the risk for intubation or death with convalescent plasma vs standard care for the treatment of patients hospitalized with COVID-19.
Impact of Diet Among Patients With HIV at Risk for Antiretroviral Therapy-Associated Weight Gain
Investigators conducted a study to determine the effects of antiretroviral therapy on weight gain in patients with HIV infection.
Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide in African American Adults With HIV Infection
Researchers conducted a study to assess virologic outcomes and adherence associated with treatment with bictegravir/emtricitabine/tenofovir alafenamide in African American patients with HIV infection.
Efficacy of First-Line Treatment With Dolutegravir/Lamivudine in Patients With Newly Diagnosed HIV Infection
Investigators conducted a secondary analysis that assessed virologic outcomes following 48 weeks of first-line treatment with dolutegravir/lamivudine in patients with newly diagnosed HIV infection.
Effects of Ritonavir-Boosted Darunavir vs Doravirine in Patients With HIV Infection
Researchers conducted a study that compared virologic suppression, lipid control, and safety profiles of patients with HIV infection who switch from ritonavir-boosted darunavir to doravirine (DOR) therapy vs those who continued DOR therapy.
Two-Drug Regimen Increases Risk for Virologic Failure in Individuals With HIV Infection
Researchers conducted a study that included patients with HIV infection who previously achieved virologic suppression to compare the risk for virologic failure among those who switch to a single-tablet 2-drug regimen vs those who switch to a single-tablet 3-drug regimen.
Does Increased Adherence to HIV PrEP With Emtricitabine/Tenofovir Decrease the Risk for Incident HIV Infection?
Researchers conducted a study to determine whether there is an association between increased adherence to HIV pre-exposure prophylaxis with daily emtricitabine/tenofovir disoproxil fumarate and a decreased risk for incident HIV infection.
- Loading...
Loading...
Next post in IDWeek 2021 HIV In-depth
Loading... 
Loading...